Offices:
Birkerod
Investors:
we tracked 6 investors
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Total investments received (USD) - we tracked 3 transactions
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Reapplix ApS, a research and development company, identifies blood-derived proteins that improve wound healing, isolates them, and reapplies them to patients with chronic wounds. The company was founded in 2008 and is based in Birkerod, Denmark.
Companies with similar profile to Reapplix:
| Company | Criteria |
|---|
 AFYX Therapeutics55% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| NMD Pharma 55% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Galecto Biotech 55% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Novo Seeds, Seed Capital
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Draupnir Bio 55% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Biosyntia 45% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Minim one investor from outside Scandinavia: Yes
|
| BioPhero 45% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Minim one investor from outside Scandinavia: Yes
|
| Acesion Pharma 45% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Minim one investor from outside Scandinavia: Yes
|
| Antag Therapeutics 45% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Novo Seeds, Vækstfonden
- Minim one investor from outside Scandinavia: Yes
|
| MinervaX 45% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Novo Seeds, Seed Capital
- Total raised in a similar range: 10M+ USD
|
 AMRA44% | - Similar business models: B2B
- At least one vc investor: Novo Seeds
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| OnRobot 44% | - Similar business models: B2B
- At least one vc investor: Vækstfonden
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Acarix 44% | - Similar business models: B2B
- At least one vc investor: Seed Capital
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Monsido 44% | - Similar business models: B2B
- At least one vc investor: Vækstfonden
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Pleo 44% | - Similar business models: B2B
- At least one vc investor: Vækstfonden
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
 Forendo Pharma44% | - Similar business models: B2B
- At least one vc investor: Novo Seeds
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Dixa 44% | - Similar business models: B2B
- At least one vc investor: Seed Capital
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| CathVision 44% | - Similar business models: B2B
- At least one vc investor: Vækstfonden
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Vivino 44% | - Similar business models: B2B
- At least one vc investor: Seed Capital
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
| Blackwood Seven 44% | - Similar business models: B2B
- At least one vc investor: Vækstfonden, Seed Capital
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
 Sanifit Therapeutics43% | - Similar verticals: Biotech
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
